Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantitative Perfusion Imaging with Total-Body PET.
Knuuti J, Tuisku J, Kärpijoki H, Iida H, Maaniitty T, Latva-Rasku A, Oikonen V, Nesterov SV, Teuho J, Jaakkola MK, Klén R, Louhi H, Saunavaara V, Nuutila P, Saraste A, Rinne J, Nummenmaa L. Knuuti J, et al. Among authors: latva rasku a. J Nucl Med. 2023 Nov;64(Suppl 2):11S-19S. doi: 10.2967/jnumed.122.264870. J Nucl Med. 2023. PMID: 37918848 Review.
A Partial Loss-of-Function Variant in AKT2 Is Associated With Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.
Latva-Rasku A, Honka MJ, Stančáková A, Koistinen HA, Kuusisto J, Guan L, Manning AK, Stringham H, Gloyn AL, Lindgren CM; T2D-GENES Consortium; Collins FS, Mohlke KL, Scott LJ, Karjalainen T, Nummenmaa L, Boehnke M, Nuutila P, Laakso M. Latva-Rasku A, et al. Diabetes. 2018 Feb;67(2):334-342. doi: 10.2337/db17-1142. Epub 2017 Nov 15. Diabetes. 2018. PMID: 29141982 Free PMC article.
The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients.
Latva-Rasku A, Honka MJ, Kullberg J, Mononen N, Lehtimäki T, Saltevo J, Kirjavainen AK, Saunavaara V, Iozzo P, Johansson L, Oscarsson J, Hannukainen JC, Nuutila P. Latva-Rasku A, et al. Diabetes Care. 2019 May;42(5):931-937. doi: 10.2337/dc18-1569. Epub 2019 Mar 18. Diabetes Care. 2019. PMID: 30885955 Free article. Clinical Trial.
Both sedentary time and physical activity are associated with cardiometabolic health in overweight adults in a 1 month accelerometer measurement.
Sjöros T, Vähä-Ypyä H, Laine S, Garthwaite T, Lahesmaa M, Laurila SM, Latva-Rasku A, Savolainen A, Miikkulainen A, Löyttyniemi E, Sievänen H, Kalliokoski KK, Knuuti J, Vasankari T, Heinonen IHA. Sjöros T, et al. Among authors: latva rasku a. Sci Rep. 2020 Nov 25;10(1):20578. doi: 10.1038/s41598-020-77637-3. Sci Rep. 2020. PMID: 33239818 Free PMC article. Clinical Trial.
Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort.
Rebelos E, Bucci M, Karjalainen T, Oikonen V, Bertoldo A, Hannukainen JC, Virtanen KA, Latva-Rasku A, Hirvonen J, Heinonen I, Parkkola R, Laakso M, Ferrannini E, Iozzo P, Nummenmaa L, Nuutila P. Rebelos E, et al. Among authors: latva rasku a. Diabetes Care. 2021 Mar;44(3):788-794. doi: 10.2337/dc20-1549. Epub 2021 Jan 14. Diabetes Care. 2021. PMID: 33446523 Free PMC article.
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study.
Oldgren J, Laurila S, Åkerblom A, Latva-Rasku A, Rebelos E, Isackson H, Saarenhovi M, Eriksson O, Heurling K, Johansson E, Wilderäng U, Karlsson C, Esterline R, Ferrannini E, Oscarsson J, Nuutila P. Oldgren J, et al. Among authors: latva rasku a. Diabetes Obes Metab. 2021 Jul;23(7):1505-1517. doi: 10.1111/dom.14363. Epub 2021 Mar 12. Diabetes Obes Metab. 2021. PMID: 33625777 Free article. Clinical Trial.
15 results